Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 5 | 2013 | 54 | 0.870 |
Why?
|
| Keratitis, Herpetic | 2 | 2013 | 18 | 0.570 |
Why?
|
| Oligosaccharides | 1 | 2014 | 24 | 0.510 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 54 | 0.490 |
Why?
|
| Arteries | 1 | 2014 | 67 | 0.490 |
Why?
|
| Betaine | 1 | 2013 | 7 | 0.480 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 34 | 0.470 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 229 | 0.460 |
Why?
|
| Antiviral Agents | 2 | 2013 | 148 | 0.440 |
Why?
|
| Virus Latency | 3 | 2012 | 42 | 0.320 |
Why?
|
| Antineoplastic Agents | 4 | 2018 | 756 | 0.310 |
Why?
|
| Endothelial Cells | 4 | 2014 | 296 | 0.280 |
Why?
|
| Chick Embryo | 5 | 2014 | 71 | 0.240 |
Why?
|
| Cyclooxygenase 2 | 2 | 2018 | 92 | 0.240 |
Why?
|
| Financing, Organized | 1 | 2022 | 11 | 0.220 |
Why?
|
| Herpes Simplex | 2 | 2012 | 16 | 0.220 |
Why?
|
| Rabbits | 5 | 2013 | 278 | 0.210 |
Why?
|
| Virus Activation | 2 | 2012 | 35 | 0.210 |
Why?
|
| Stromal Cells | 2 | 2012 | 45 | 0.210 |
Why?
|
| Herpesvirus 8, Human | 2 | 2014 | 25 | 0.210 |
Why?
|
| Host-Pathogen Interactions | 2 | 2014 | 179 | 0.200 |
Why?
|
| Cell Movement | 4 | 2018 | 545 | 0.200 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 129 | 0.200 |
Why?
|
| Animals | 14 | 2016 | 14307 | 0.190 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 2128 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2022 | 371 | 0.160 |
Why?
|
| Metformin | 1 | 2018 | 64 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1300 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2014 | 392 | 0.140 |
Why?
|
| Biology | 1 | 2016 | 15 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 40 | 0.140 |
Why?
|
| Models, Educational | 1 | 2016 | 41 | 0.140 |
Why?
|
| Educational Measurement | 1 | 2016 | 80 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 386 | 0.130 |
Why?
|
| Mice | 6 | 2016 | 5668 | 0.130 |
Why?
|
| Integrin alpha4 | 1 | 2014 | 2 | 0.130 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 30 | 0.130 |
Why?
|
| Humans | 16 | 2022 | 34853 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 68 | 0.130 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 2 | 2014 | 70 | 0.120 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 16 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 69 | 0.120 |
Why?
|
| Thiazoles | 1 | 2014 | 71 | 0.120 |
Why?
|
| Cell Communication | 1 | 2014 | 93 | 0.120 |
Why?
|
| Pyridines | 1 | 2014 | 113 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1149 | 0.120 |
Why?
|
| Cornea | 1 | 2013 | 55 | 0.120 |
Why?
|
| Matrix Metalloproteinase 15 | 1 | 2012 | 1 | 0.110 |
Why?
|
| DNA, Viral | 2 | 2012 | 295 | 0.110 |
Why?
|
| Eye Infections, Viral | 1 | 2012 | 4 | 0.110 |
Why?
|
| Virus Shedding | 1 | 2012 | 9 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 72 | 0.110 |
Why?
|
| Adipocytes | 1 | 2012 | 54 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 303 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 111 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 341 | 0.110 |
Why?
|
| Saliva | 1 | 2012 | 97 | 0.100 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2011 | 10 | 0.100 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 9 | 0.100 |
Why?
|
| Glucose | 1 | 2012 | 217 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 16 | 0.100 |
Why?
|
| Students | 1 | 2016 | 452 | 0.100 |
Why?
|
| Keratinocytes | 1 | 2011 | 65 | 0.100 |
Why?
|
| Minority Groups | 1 | 2016 | 537 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2014 | 486 | 0.100 |
Why?
|
| Eye | 1 | 2011 | 68 | 0.090 |
Why?
|
| Retina | 1 | 2012 | 255 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 122 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1426 | 0.090 |
Why?
|
| Peptides | 1 | 2012 | 308 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2011 | 298 | 0.080 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 68 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 1530 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2014 | 1802 | 0.070 |
Why?
|
| Hemophilia A | 1 | 2005 | 4 | 0.070 |
Why?
|
| Blood Component Transfusion | 1 | 2005 | 4 | 0.070 |
Why?
|
| HIV Antibodies | 1 | 2005 | 29 | 0.070 |
Why?
|
| Serum | 1 | 2005 | 13 | 0.070 |
Why?
|
| Obesity | 1 | 2012 | 965 | 0.060 |
Why?
|
| Dinoprostone | 2 | 2018 | 57 | 0.060 |
Why?
|
| Chorioallantoic Membrane | 2 | 2014 | 10 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2014 | 376 | 0.060 |
Why?
|
| Writing | 1 | 2022 | 33 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 247 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2022 | 35 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 77 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 968 | 0.050 |
Why?
|
| Dipeptides | 2 | 2012 | 29 | 0.050 |
Why?
|
| Recurrence | 2 | 2012 | 125 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 600 | 0.050 |
Why?
|
| Female | 5 | 2018 | 19873 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2012 | 562 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 416 | 0.040 |
Why?
|
| Data Mining | 1 | 2016 | 21 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 1289 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 115 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 256 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 298 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 429 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 87 | 0.030 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 89 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 64 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 46 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 107 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 56 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 323 | 0.030 |
Why?
|
| Curriculum | 1 | 2016 | 237 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 80 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 162 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 430 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 211 | 0.030 |
Why?
|
| Drug Design | 1 | 2014 | 154 | 0.030 |
Why?
|
| Tears | 1 | 2012 | 11 | 0.030 |
Why?
|
| United States | 1 | 2022 | 3894 | 0.030 |
Why?
|
| Binding Sites | 1 | 2014 | 597 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2014 | 287 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 233 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 136 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 157 | 0.030 |
Why?
|
| Stem Cells | 1 | 2012 | 132 | 0.030 |
Why?
|
| HIV Infections | 1 | 2005 | 2207 | 0.030 |
Why?
|
| Transfection | 1 | 2012 | 496 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2011 | 16 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 44 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 40 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 71 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 300 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1442 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2011 | 108 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 391 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 751 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 202 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 240 | 0.020 |
Why?
|
| Aorta | 1 | 2011 | 161 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 605 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 485 | 0.020 |
Why?
|
| Proviruses | 1 | 2005 | 27 | 0.020 |
Why?
|
| AIDS Serodiagnosis | 1 | 2005 | 25 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 3261 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 1961 | 0.010 |
Why?
|
| Male | 1 | 2016 | 18870 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 6448 | 0.010 |
Why?
|
| Middle Aged | 1 | 2005 | 9642 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 11034 | 0.010 |
Why?
|